Theranexus SA (ALTHX) Stock Statistics & Valuation Metrics

Theranexus SA has a market cap or net worth of €19.88M. The enterprise value is €6.78M.

Theranexus SA has 7,758,724 shares outstanding. The number of shares has decreased by -2.65% in one year.

Theranexus SA’s return on equity (ROE) is 1.07 and return on invested capital (ROIC) is -516.23%.

The current PE Ratio of Theranexus SA is ―. Theranexus SA’s PEG ratio is 0.04.

In the last 12 months, Theranexus SA had revenue of 2.28M and earned -1.77M in profits. Earnings per share was -0.21.

In the last 12 months, operating cash flow was -2.82M and capital expenditures -2.62K, giving a free cash flow of -2.83M billion.

Theranexus SA pays an annual dividend of ―, resulting in a dividend yield of ―

Theranexus SA upcoming earnings date is May 5, 2026, Before Open (Not Confirmed).

Theranexus SA as a current ratio of 0.70, with Debt / Equity ratio of -173.29%

In the past 12 months, Theranexus SA has paid 768.08K in taxes.

Theranexus SA EV to EBITDA ratio is -2.80, with an EV/FCF ratio of -2.08.

Theranexus SA has €966.59K in cash and marketable securities with €2.87M in debt, giving a net cash position of -€1.90M billion.

Gross margin is -1988.71%, with operating margin of -210.66%, and net profit margin of -77.30%.

The average price target for Theranexus SA is €2.50, which is 11.43% higher than the current price. The consensus rating is Hold